Nirat Beohar, M.D., has devoted his career to the use and development of catheter-based therapies for the treatment of heart disease. Dr. Beohar completed a fellowship in interventional cardiology at the Feinberg Medical School and a cardiology fellowship at George Washington University in Washington, D.C. He also was a visiting fellow at the Laboratory of Molecular Cardiology at the National Heart, Lung, and Blood Institute, and completed post graduate training in internal medicine at the Baylor College of Medicine in Houston, Texas.

Dr. Beohar is vice chief of the Columbia University Division of Cardiology at Mount Sinai Medical Center and director of the hospital’s cardiac catheterization lab. He is also medical director of the hospital’s Structural Heart Disease Program, program director for the hospital’s Interventional Cardiology Fellowship Program and a professor at Columbia University Medical Center. He holds board certification in interventional cardiology, nuclear cardiology, CT angiography and cardiology.

Prior to joining Mount Sinai-Columbia, Dr. Beohar was an interventional cardiologist at Northwestern Memorial Hospital in Chicago, and associate professor of medicine at Northwestern University’s Feinberg School of Medicine. He previously was the director of the cardiac catheterization laboratory at the Veterans Administration Lakeside Hospital in Chicago. Dr. Beohar has a broad repertoire of catheter-based therapies. He has extensive expertise in implanting catheter-delivered heart aortic valves. He is expert treating complex coronary conditions such as left main and multi-vessel disease, as well as chronic total occlusions. He has expertise with devices to close atrial septal defects, PFOs, and other intracardiac shunts. For patients in cardiogenic shock, he implants left ventricular assist devices such as the Tandem heart and Impella. He also is skilled in transseptal catheterization, a highly specialized technique used to access the left side of the heart to treat structural heart disease. Additionally, he has had experience with percutaneous therapies for peripheral vascular disease.

*This physician is employed by Mount Sinai Medical Center